Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke

During the past decades, candidate drugs that have shown neuroprotective efficacy in the preclinical setting have failed in clinical stroke trials. As a result, no treatment for stroke based on neuroprotection is available today. The activation of the glucagon-like peptide 1 receptor (GLP-1) for red...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cereb Blood Flow Metab
Auteurs principaux: Darsalia, Vladimer, Larsson, Martin, Nathanson, David, Klein, Thomas, Nyström, Thomas, Patrone, Cesare
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Mini Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420864/
https://ncbi.nlm.nih.gov/pubmed/25669907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires